RZ/]X-<][)1]$!P4@,{T)FC@C!!
SYSTEM PROCESSING...
RZ/]X-<][)1]$!P4@,{T)FC@C!!
SYSTEM PROCESSING...
Posted: 2025-05-03 06:36:52 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-05-03 06:38:14 UTC
Verified By
Rollup News
Early clinical testing of CRISPR/Cas9-edited immune cells targeting the CISH gene shows safety and potential in stopping advanced gastrointestinal cancer progression.
CRISPR/Cas9 gene editing
CISH gene target
Advanced gastrointestinal cancer
Early clinical trial results
Immune cell therapy
Advanced stage of cancer
Ensuring long-term safety of gene-edited cells
Scaling up production of modified immune cells
Overcoming potential immune resistance